Keros Therapeutics, Inc.
KROS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$187,353 | -$152,992 | -$104,679 | -$58,744 |
| Dep. & Amort. | $1,229 | $815 | $674 | $378 |
| Deferred Tax | $0 | $0 | $0 | $46 |
| Stock-Based Comp. | $34,872 | $28,763 | $18,682 | $11,722 |
| Change in WC | -$11,437 | -$2,650 | $14,308 | -$16,070 |
| Other Non-Cash | $1,820 | $1,556 | $953 | $520 |
| Operating Cash Flow | -$160,869 | -$124,508 | -$70,062 | -$62,148 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,931 | -$2,464 | -$1,241 | -$1,024 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$1,931 | -$2,464 | -$1,241 | -$1,024 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $380,134 | $175,825 | $119,578 | $28,171 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $11,687 | $3,131 | $731 | $379 |
| Financing Cash Flow | $391,821 | $178,956 | $120,309 | $28,550 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $229,021 | $51,984 | $49,006 | -$34,622 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $332,359 | $280,375 | $231,369 | $265,991 |
| End Cash | $561,380 | $332,359 | $280,375 | $231,369 |
| Free Cash Flow | -$162,800 | -$126,972 | -$71,303 | -$63,172 |